Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-20

Clinical Trial Update: Impact of Platelet Activation in Intracranial Aneurysm Rupture Risk - PLAQRAN

View source ↗

Summary

The PLAQRAN trial investigates how platelet activation relates to rupture risk in intracranial aneurysms and is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Fondation Ophtalmologique Adolphe de Rothschild | Conditions: Intracranial Aneurysms, Ruptured Aneurysm | Status: ACTIVE_NOT_RECRUITING